Literature DB >> 20861496

The pathologist's slide reveals more than meets the eye: loss of heterozygosity and cancer biology.

S S Couto1.   

Abstract

In the postgenomic era, the accumulation of massive amounts of molecular and genetic data is quickly transforming the landscape of cancer research. A deeper understanding of cancer biology will allow pathologists studying genetically engineered mouse models and spontaneous tumors to ask novel questions and provide useful insights into disease mechanisms. Although tumor suppressor gene loss is known to be an essential step in the pathogenesis of many tumors, the variety of mechanisms that lead to such loss are poorly understood. This article provides an overview of loss of heterozygosity as an important mechanism of tumor suppressor gene loss; it also emphasizes the importance of loss of heterozygosity detection as a tool for tumor suppressor gene discovery. Understanding the applications of the array of molecular techniques currently available in cancer research will enable pathologists to further contribute to the advancement the field.

Entities:  

Mesh:

Year:  2010        PMID: 20861496     DOI: 10.1177/0300985810379432

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  5 in total

1.  Screening of cerebral infarction-related genetic markers using a Cox regression analysis between onset age and heterozygosity at randomly selected short tandem repeat loci.

Authors:  Liu Hui; Tian Jun; Ye Jing; Weijian Yu
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.

Authors:  S Dholariya; R Mir; M Zuberi; P Yadav; G Gandhi; N Khurana; A Saxena; P C Ray
Journal:  Clin Transl Oncol       Date:  2015-07-25       Impact factor: 3.405

3.  Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.

Authors:  Zhengmao Zhang; Hanwen Bai; Jon Blumenfeld; Andrew B Ramnauth; Irina Barash; Martin Prince; Adrian Y Tan; Alber Michaeel; Genyan Liu; Ines Chicos; Lior Rennert; Stavros Giannakopoulos; Karen Larbi; Stuart Hughes; Steven P Salvatore; Brian D Robinson; Sandip Kapur; Hanna Rennert
Journal:  J Am Soc Nephrol       Date:  2021-10-29       Impact factor: 10.121

4.  Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.

Authors:  Mark R Openshaw; Ali A Mohamed; Barbara Ottolini; Daniel Fernandez-Garcia; Cathy J Richards; Karen Page; David S Guttery; Anne L Thomas; Jacqui A Shaw
Journal:  Br J Cancer       Date:  2020-07-28       Impact factor: 7.640

Review 5.  Mutational drivers of cancer cell migration and invasion.

Authors:  Nikita M Novikov; Sofia Y Zolotaryova; Alexis M Gautreau; Evgeny V Denisov
Journal:  Br J Cancer       Date:  2020-11-18       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.